Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
In the coming years there will probably be a Cardio-Oncology ‘epidemic’ due to either the growing population of cancer survivors, the increasing number of patients aged over 65 who need chronic cancer therapy and the high frequency of cancer therapy induced CVDs in these populations. The main goal of Cardio-Oncology is to reduce the burden of CVDs in oncologic patients allowing them to receive the best antitumor therapy (chemotherapy, targeted molecular therapies, hormone therapy, immunotherapy or radiotherapy) with the lowest rate of side effects and treatment interruptions.
Consequently, the ESC created the Council of Cardio-Oncology in August 2018 as a multidisciplinary constituent body which encourages the prevention, early diagnosis and management of cancer therapy-related cardiovascular diseases.
ESC Councils' Internal Governance Procedures
Our aims are to bring together European & non-European specialists in the field and specialists from Oncology, Hematology, Radiotherapy and related disciplines to improve the prevention, diagnosis, treatment and management of cancer therapy-related cardiovascular diseases and enhance the standard of care for Cardio-Oncology patients.
We work in line with the ESC Strategic Pillars: Advocacy, Congresses, Research, Membership and Education.
The Council is active in a number of areas, including :
Read the 2019-2020 Activity Report from the Council of Cardio-Oncology
Membership is free.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.